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cu.2012.Abstract A sensitive and simple ﬂuorimetric method was developed for the determination of
diosmin and hesperidin. The proposed method involves the formation of ternary complex with
Tb3+ in the presence of Tris buffer. The ﬂuorescence quenching of Tb3+ at 549 and 494 nm (kex
at 275 and 248 nm) due to the complex formation was quantitatively measured for diosmin and
hesperidin, respectively. The reaction conditions and the ﬂuorescence spectral properties of the
complexes have been investigated. Under the described conditions, the proposed method was appli-
cable over the concentration range (4.93 · 106–1.81 · 105 mol) and (3.28 · 106–1.64 · 105 mol)
with mean percentage recoveries 100.22 ± 0.89 and 99.13 ± 0.72 for diosmin and hesperidin,
respectively. The proposed method was applied successfully for the determination of studied drugs
in bulk powder, dosage forms and plasma samples. The results obtained by applying the described
method were statistically analyzed and compared with those obtained by applying a reported
method. The method was validated according to ICH recommendations.
ª 2013 Faculty of Pharmacy, Cairo University. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Flavonoids are important polyphenolic secondary metabolites
that are widely distributed in medicinal plants and foods of
plant origin providing much of the ﬂavor and color to fruits33388468/37628093, mobile:
om (D. Mohamed).
aculty of Pharmacy, Cairo
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, Cairo University. Production and
12.001and vegetables.1 Among these ﬂavonoids; the ﬂavone glycoside
diosmin (30,5,7-trihydroxy- 40-methoxyﬂavone 7-rutinoside)
and its ﬂavanone analog hesperidin (30,5,7-trihydroxy-40-
methoxyﬂavanone 7-rhamnoglycoside). The two ﬂavonoids
are common constituents in many citrus species.1,2 Diosmin
and hesperidin possess antioxidant, blood lipid lowering,
anti-carcinogenic activities.3,4 In addition, both drugs improve
venous tone, enhance microcirculation, assist healing of
venous ulcers and they are used for the treatment of chronic
venous insufﬁciency, hemorrhoids and the prevention of post-
operative thromboembolism.1 In view of the increasing interest
in these bioﬂavonoids, especially for the treatment of chronic
venous insufﬁciency, chronic hemorrhoids and as antioxidants,
several methods have been reported for the determination ofhosting by Elsevier B.V.Open access under CC BY-NC-ND license.
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dosage forms, the majority of which are chromatographic in nat-
ure.1–3,5–11 In addition, capillary electrophoretic techniques12–14
as well as electrochemical methods have been also used for the
determination of both drugs.15–18 However, few spectrophoto-
metric methods for analyzing diosmin19–21 and hesperidin20,22,23
have been found in the literature. Although ﬂuorimetric methods
of analysis offer great sensitivity and selectivity for the determi-
nation of a large number of analytes, however, to the best of
our knowledge, no spectroﬂuorimetric method is available in
the literature for the determination of diosmin. In addition two
methods were developed for the determination of hesperidin
based on the formation of ﬂuorescent metal chelates either with
magnesium24 or aluminum25, however, they lack application to
the determination of the drug in dosage forms or in plasma.
Where, the latter method was applied for the determination of
hesperidin in orange peel and orange juice.
Luminescence spectrometry offers possibilities of sensitive
and selective detection, by the use of lanthanide sensitized
luminescence. The speciﬁc strong ﬂuorescence of lanthanide
ions, which usually occurs as a result of intramolecular energy
transfer through the excited triplet state of the ligand to the
emitting level of the lanthanide ion, is characterized by large
Stokes shifts, narrow emission bands and long ﬂuorescence life-
times.26 As a result of spectral and temporal discrimination of
the analytical signal, background ﬂuorescent emission interfer-
ences from the complex matrices are eliminated, selectivity and
detection limits are improved. In some instances, however,
when the organic compound has a triplet state level below the
excited state level of the lanthanide ion, the organic compound
can quench the background luminescence of the ion.27,28 The
sensitizing or quenching effect is more important with chloride
than the nitrate salts of the lanthanide, because the probability
of collision leading to energy transfer is larger for the chloride
salt.27,28 Based on energy level considerations and luminescence
quantum yields, Tb3+ and Eu3+ are the best lanthanide ions to
be applied to the determination of organic compounds. The ter-
bium metal ion (Tb3+) has been the lanthanide of choice in
most applications of ternary complex formation and was used
as ﬂuorescent probes for the determination of several com-
pounds.29–35
The lack of spectroﬂuorimetric methods for the analysis of
both diosmin and hesperidin in combined dosage forms and in
plasma has motivated us to develop a speciﬁc and sensitive
spectroﬂuorimetric method for their determination. This meth-
od is based on the quenching of ﬂuorescence produced by these
drugs on Tb3+ – Tris system. The ﬂuorescence properties were
investigated using different buffer systems and different sol-
vents. Factors affecting complexation such as the concentra-
tion of Tb3+ and the ratio of Tb3+ to the studied drugs
were carefully investigated. The method was subsequently used
to determine the concentration of the drugs in dosage forms
and in spiked plasma samples. Our experimental results were
validated by a well-established reported method.2. Materials and Methods
2.1. Instrumentation
The spectroﬂuorimetric measurements were performed using a
Jasco FP-6200 Spectroﬂuorometer using quartz cell, bandwidth (ex): 5 nm, band width (em): 5 nm, response: medium,
sensitivity: medium, scanning speed: 250 nm/min. For buffer
preparation a digital pH meter, HANNA instruments
HI2211 pH/ORP Meter was used.
2.2. Chemicals and reagents
Diosmin and hesperidin were obtained as gifts from Sedico
Pharmaceutical Co., 6 October City, Egypt. Their purities were
certiﬁed and analyzed by a reported method3 and were found
to be 99.44% and 98.54%, respectively. They were used as pro-
vided. Terbium chloride 99.99% was obtained from Sigma–
Aldrich, St. Louis, USA. It was prepared as 2 · 103 M in
methanol. Tris(hydroxyl methyl)amino methane was pur-
chased from Fluka-Biochemica, St. Louis, USA. Tris buffer
was prepared by dissolving 2 g of Tris and 2.4 g of sodium
chloride in 100 ml distilled water, pH was adjusted with 1 M
HCl and then the volume was diluted to 200 ml with distilled
water. Methanol and sodium hydroxide were obtained from
Sigma–Aldrich, St. Louis, USA. Hydrochloric acid was pur-
chased from Riedel-de Haen, Seelze, Germany. Acetonitrile
was obtained from Merck, Darmstadt, Germany. Sodium
chloride, boric acid and dipotassium hydrogen orthophos-
phate were purchased from ADWIC; El Nasr Pharmaceutical
Chemicals, Egypt.
Dosage forms of Daﬂon 500 mg Tablets: Diosmin 450 mg,
Hesperidin 50 mg B.N. 17162 (Servier Egypt Industries
Limited, 6th October City, Giza, Egypt), Dioven 500 Tablets:
Diosmin 500 mg B.N. 614710[A] (Amriya Pharm Ind.,
Alexandria, Egypt), Diosed C 500 mg Tablets: Diosmin
450 mg, Hesperidin 50 mg B.N. 1209195 (Sedico Pharmaceuti-
cal Co., 6 October City, Egypt), Veinatonic Tablets: Diosmin
450 mg, Hesperidin 50 mg B.N. 12227 (Sigma Pharmaceutical
Industries, Egypt, S.A.E.) were purchased from local market.
Human Plasma: B.N. 1005250102 was obtained from Vacsera,
Giza, Egypt.
2.3. Standard solutions
Diosmin (1.64 · 104 mol), was prepared by dissolving the
appropriate amount in a 100 ml volumetric ﬂask in 5 ml of
0.1 N NaOH and the volume was completed to the mark with
methanol, dissolution was aided by sonication. Hesperidin
(1.64 · 104 mol) in methanol, dissolution was aided by soni-
cation. The stock solutions of both drugs were protected from
daylight and stored in a refrigerator.
2.4. Procedures
2.4.1. Construction of calibration curve
2.0 ml of terbium solution (2 · 103 mol) was transferred into
a series of 10 ml volumetric ﬂasks. Aliquots equivalent to
4.93 · 105–1.81 · 104 mol for diosmin and 3.28 · 105–
1.64 · 104 mol for hesperidin were transferred from the corre-
sponding stock solutions, followed by 2 ml of Tris buffer of pH
8 and pH 8.5 for diosmin and hesperidin, respectively. The vol-
ume was completed with distilled water. The solution was left
for 15 min then the ﬂuorescence quenching was measured at
549 and 494 nm using 275 and 248 nm as excitation wave-
lengths for diosmin and hesperidin, respectively. The concen-
tration versus the decrease in ﬂuorescence intensity was
Figure 1 (a) Emission spectra at 549 nm; 1. Tb3+ – Tris (pH
8.0); 2. Tb3+ – Tris – Diosmin (1.48 · 105 mol); 3. Tb3+; 4.
Diosmin (1.48 · 105 mol). (b) Emission spectra at 494 nm; 1.
Tb3+ – Tris (pH 8.5); 2. Tb3+ – Tris – Hesperidin
(1.15 · 105 mol); 3. Tb3+; 4. Hesperidin (1.15 · 105 mol).
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ear regression equations were computed.
2.4.2. Procedure for dosage forms
2.4.2.1. Dioven 500 tablets. Five tablets were pulverized well;
an accurate amount of the powdered tablets was weighed
and transferred to a 100 ml volumetric ﬂask. The drug was dis-
solved in 5 ml of 0.1 N NaOH and the volume was completed
to the mark with methanol to obtain 100 ml of 1.64 · 104 mol
diosmin. The resulting solution was sonicated for 30 min and
ﬁltered then the procedure described under calibration curve
was carried out.
2.4.2.2. Daﬂon 500, Diosed C and veinatonic tablets.
For diosmin determination: Five tablets were pulverized well; an
accurate amount of the powdered tablets was weighed and
transferred to a 150 ml beaker. Then 25 ml of methanol was
added and the resulting mixture was sonicated for 30 min and
ﬁltered. The ﬁltrate (containing hesperidin) was rejected. The
residue (containing diosmin) was collected in the beaker and
dissolved in 5 ml 0.1 N NaOH then transferred quantitatively
to a 100 ml volumetric ﬂask with the aid of methanol. The vol-
ume was completed to the mark with methanol to obtain 100 ml
of 1.64 · 104 mol diosmin. The resulting solution was
sonicated for 30 min and ﬁltered. Finally the procedure was
completed as described under calibration curve.
For hesperidin determination: Five tablets were pulverized
well; an accurate amount of the powdered tablets was weighed
and transferred to a 100 ml volumetric ﬂask. The drug was dis-
solved in methanol and the volume was completed to the mark
with methanol to obtain 100 ml of 1.64 · 104 mol hesperidin.
The resulting solution was sonicated for 30 min and ﬁltered
then the procedure described under calibration curve was car-
ried out.
2.4.3. Procedure for spiked human plasma
Plasma samples were stored at 80 C then thawed at room
temperature on the day of analysis. One ml aliquots of human
plasma were transferred into a series of centrifugation tubes,
spiked with increasing quantities of diosmin and hesperidin
to give a ﬁnal concentration range of 4.93 · 106–
1.81 · 105 mol and 3.28 · 106–1.64 · 105 mol, respectively.
Then 2.5 ml of acetonitrile was added and centrifugation at
6000 rpm for 45 min was performed. Aliquots from the clear
supernatant were transferred quantitatively to 10 ml volumet-
ric ﬂasks and evaporated to dryness. The residue was reconsti-
tuted in the dissolving solvents and the steps described under
calibration curve were carried out.
3. Results and discussion
3.1. Spectral characteristics
The ﬂuorescence spectra of diosmin and hesperidin in their dis-
solving solvents were investigated, it was observed that both
drugs showed no notable ﬂuorescence. The spectral character-
istics of Tb3+ in methanol are shown in Fig. 1. A very weak
ﬂuorescence could be detected which was not surprising. It is
well known that generally lanthanide ions emit weak ﬂuores-
cence because of the weak absorption bands, and because they
can be non-radiatively deactivated by the solvent molecules.36However, addition of Tris buffer to Tb3+ solution resulted in
an intense emission at 549 and 494 nm after excitation at kex
275 and 248 nm. Clearly, the intensity of the emission line
was greatly enhanced in the presence of Tris buffer as com-
pared to Tb3+ alone. On adding the studied drugs immediate
ﬂuorescence quenching was observed. This phenomenon could
be attributed to the level of the triplet state of the organic com-
pounds which is below the excited state level of the lanthanide
ion, so, the organic compounds can quench the background
luminescence of the ion. The relative emission spectra are
shown in Fig. 1. The decrease in ﬂuorescence intensity was
proportional to the concentration of the added drugs at kem
549 and 494 nm (kex 275 and 248 nm) for diosmin and hesper-
idin, respectively.
3.2. Method optimization
Having established that diosmin and hesperidin caused ﬂuores-
cence quenching of the Tb3+ – Tris complex; we embarked on
studying the optimum reaction conditions.
3.2.1. Effect of pH
The maximum ﬂuorescence quenching of the drug solutions
was studied by varying the pH of Tris buffer in the range pH
5.5–10.0 while keeping other experimental factors constant.
Fig. 2 shows that on increasing the pH, ﬂuorescence quenching
increases and reaches maximum at pH 8.0 and 8.5 for diosmin
and hesperidin, respectively. However, when the pH was
Figure 2 Effect of different pH values on the reaction between
Tb3+ and Tris buffer with diosmin (1.48 · 105 mol) and hesper-
idin (1.15 · 105 mol).
Figure 4 Effect of Tris buffer volume on the reaction of Tb3+
with diosmin (1.48 · 105 mol) and hesperidin (1.15 · 105 mol).
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creased sharply. At pH higher than 10.0, non-reproducible
quenching was observed which is attributed to the competitive
hydrolysis of Tb3+ with the deposition of Tb(OH)3. So, the
choice of the suitable pH was critical for obtaining maximum
ﬂuorescence quenching by the drugs.
3.2.2. Effect of buffer
The experiments indicated that the kind of buffer has a great
inﬂuence on both the enhancement of the ﬂuorescence intensity
of Tb3+ ions as well as the quenching of ﬂuorescence of the
Tb3+––Tris complex by the studied drugs. So, different buffers
including Tris, borate and phosphate buffers at the chosen pH
were tested (Fig. 3). The results indicated that Tris buffer
showed the sharpest increase in the ﬂuorescence intensity ofFigure 3 Effect of different buffer types on the reaction of Tb3+
with diosmin (1.48 · 105 mol) and hesperidin (1.15 · 105 mol).Tb3+ ions. Similar behavior was previously observed by several
authors, where it was reported that Tris buffer may chelate with
Tb3+ to give an intense ﬂuorescence.27,28,31 In addition, Tris
buffer also resulted in the best quenching of ﬂuorescence upon
addition of diosmin and hesperidin. It is worthy to note that,
several cephalosporin antibiotics27 as well as some sulfur con-
taining drugs28 were reported to cause quenching of the ﬂuores-
cence of Tb3+––Tris complex. Also the effect of volume of Tris
buffer was studied and it was found that 2 ml was adequate for
complete reaction (Fig. 4).
3.2.3. Effect of Tb3+ ion concentration
The effect of Tb3+ concentration on ﬂuorescence intensity was
studied by using different volumes of terbium chloride
(2 · 103 mol). It was found that 2 ml was appropriate for pro-
ducing maximum intensity of the emission line of terbium ions,Figure 5 Effect of Tb3+ volume (2 · 103 M) on the reaction of
Tb3+ with diosmin (1.48 · 105 mol) and hesperidin
(1.15 · 105 mol).
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(Fig. 5). In addition, the stoichiometry of the reaction was
studied by the molar ratio and it was found to be 1 Tb: 3 drug.
3.2.4. Effect of diluting solvents
It is a well known phenomenon that the type of solvent used
inﬂuences the luminescence intensity of the molecule. Therefore
an attempt was made to study the effect of different solvents
(water, methanol, ethanol and acetonitrile) on the luminescence
intensity of the Tb3+––Tris––drug complex. It was found that
optimum conditions are obtained when using water as a solvent.
This conclusion is in agreement with the literature stating that
water molecules strongly quench terbium sensitized lumines-
cence.32 The low sensitization in water may be due to the O–H
oscillators of water molecules that are known to quench the ex-
cited state of the lanthanide ions by interactionwith high-energy
vibrations associatedwithO–H.Other solventmolecules such as
methanol or ethanol can usually replace coordinated water and
avoid high frequency O–H bond vibration, thus greatly decreas-
ing energy loss resulting through the coordination of water mol-
ecules, and increasing the ﬂuorescence intensity of the emitting
lanthanide ion.29 This suggests that the chemical environment
plays an important role in determining the ﬂuorescence intensity
of the complexes; hence the choice of water was ideal in studying
the luminescence of the Tb3+––Tris––drug complex.
3.2.5. Stability test
The experiments indicated that the ﬂuorescence intensity of the
system reached a maximum in 15 min after all reagents had
been added and remained stable for at least 1 h.
3.3. Method validation
3.3.1. Linearity and range
The calibration graphs for the determination of diosmin and
hesperidin by the proposed method were constructed under
the optimum experimental conditions. The graphs were found
to be rectilinear in the concentration ranges of 4.93 · 106–
1.81 · 105 mol and 3.28 · 106–1.64 · 105 mol for diosminTable 1 Performance data for diosmin and hesperidin by the
proposed ﬂuorimetric method.
Parameter Diosmin Hesperidin
Linearity range 4.93 · 106–1.81
· 105 mol
3.28 · 106–1.64
· 105 mol
Regression equation DFI = 1.27 · 107
C+ 1.66
DFI = 1.23 · 107
C+ 8.16
Slope (b) 1.27 · 107 1.23 · 107
Intercept (a) 1.66 8.16
Correlation
coeﬃcient (r)
0.9999 1
SE of slope 1.07 · 105 5.05 · 104
SE of intercept 1.33 0.55
Sy/x 1.12 0.52
LOD 2.91 · 107 1.40 · 107
LOQ 8.82 · 107 4.23 · 107
DFI = a+ bc, DFI = relative ﬂuorescence intensity, a= inter-
cept, b= slope, C= concentration in mol, Sy/x = standard devi-
ation of residuals, LOD= limit of detection, LOQ= limit of
quantitation.and hesperidin, respectively, and with the regression equations
cited in Table 1.
3.3.2. Accuracy
The accuracy of the proposed method was evaluated by ana-
lyzing six levels of standard solutions of the studied drugs,
each three times. The mean percentage recoveries obtained
by the proposed method were found to be 100.22 ± 0.89 and
99.13 ± 0.72 for diosmin and hesperidin, respectively. These
results were favorably compared with those of a reported
one.3 Statistical analysis37 obtained by the proposed and re-
ported methods using Student’s t-test and variance ratio F-test,
showed no signiﬁcant difference between the performance of
the two methods as indicated by the smaller calculated values
compared to the corresponding theoretical values of t and F
(Table 2).
3.3.3. Precision
The intraday precision was evaluated through replicate analy-
sis of the standard solutions of the drugs. Whereas the interday
precision was performed through replicate analysis of the stan-
dard solutions of the drugs on three successive days. The per-
centage recoveries as well as the percentage relative standard
deviations were calculated as abridged in Table 3.
3.3.4. Selectivity
The selectivity of the method was investigated by observing
any interference encountered from the common tablet excipi-
ents such as talc, lactose, starch and magnesium stearate. It
was found that these compounds did not interfere with the as-
say of the proposed method.
3.3.5. Limit of detection (LOD) and limit of quantitation
(LOQ)
The limit of detection (LOD) and limit of quantitation (LOQ)
were calculated according to ICH recommendations.38 The
LOD was found to be 2.91 · 107 and 1.4 · 107 while theTable 2 Statistical comparison for the results obtained by the
proposed ﬂuorimetric method and a reported one3 for the
analysis of diosmin and hesperidin in pure form.
Item Diosmin Hesperidin
Proposed Reported3** Proposed Reported3**
Mean* 100.22 99.44 99.13 98.54
±SD 0.89 0.79 0.72 0.66
% RSD 0.89 0.80 0.73 0.67
% REr 0.36 0.40 0.30 0.34
Variance 0.79 0.63 0.52 0.44
t-Test 1.41. . .. . ....(2.31) 1.30. . .. . ....(2.31)
F-test 1.25. . .. . ....(9.013) 1.19. . .. . ....(9.013)
S.D. = standard deviation, % RSD= percent relative standard
deviation, % REr = percent relative standard error, the values in
parenthesis are the corresponding theoretical values of t and F at
P= 0.05, where n= 6 for the proposed method and n= 4 for the
reported method.
* Average of three determinations.
** The reported method is an HPLC method using LiChrosorb RP-
18 column, a mixture of methanol–water (60:40, v/v) as a mobile
phase in an isocratic mode at a ﬂow rate of 1.5 ml/min and UV
detection at 345 nm.
Table 3 Intraday and interday statistical data for the studied drugs in pure form by the proposed ﬂuorimetric method.
Parameter Concentration of diosmin in mol Concentration of hesperidin in mol
4.93 · 106 1.15 · 105 1.81 · 105 3.28 · 106 9.83 · 106 1.64 · 105
Intraday
Mean* (X) 100.72 99.33 100.51 99.93 98.04 99.35
±S.D 0.48 0.86 0.86 0.59 0.95 0.78
% R.S.D 0.48 0.86 0.85 0.59 0.97 0.79
% REr 0.27 0.50 0.49 0.34 0.56 0.45
Variance 0.23 0.73 0.73 0.35 0.90 0.61
Interday
Mean* (X) 101.05 99.80 100.48 98.98 100.70 99.31
±S.D 0.72 1.06 0.45 1.03 0.77 0.70
% R.S.D 0.71 1.06 0.45 1.04 0.76 0.71
% REr 0.41 0.61 0.26 0.60 0.44 0.41
Variance 0.51 1.13 0.21 1.06 0.59 0.49
* Average of three determinations.
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idin, respectively as cited in Table 1.
3.3.6. Robustness of the method
The robustness of the method adopted was demonstrated by
the consistency of the ﬂuorescence values with the deliberate
minor changes in the experimental parameters. So, when
changing the pH value of Tris buffer by ±0.2 units or varyingTable 4 Statistical comparison for the results obtained by the propo
diosmin in its dosage forms.
Item Diosed C 500 mg tablets Veinatonic tablets
Proposed Reported3 Proposed Report
Mean* 97.82 97.18 99.02 98.23
±SD 0.77 0.62 0.50 0.76
% RSD 0.79 0.64 0.51 0.78
% REr 0.32 0.32 0.21 0.39
Variance 0.59 0.39 0.25 0.58
t-Test 1.39. . .. . .... . .(2.31) 1.99. . .. . .... . .(2.31)
F-test 1.52. . .. . ..... . .(9.013) 2.31. . .. . ..... . .(5.409)
The values in parenthesis are the corresponding theoretical values of t and
the reported method.
* Average of three determinations.
Table 5 Statistical comparison for the results obtained by the propo
hesperidin in its dosage forms.
Item Diosed C 500 mg tablets
Proposed Reporte
Mean* 97.36 97.93
±SD 0.69 0.66
% RSD 0.71 0.67
% REr 0.29 0.34
Variance 0.48 0.43
t-Test 1.30. . .. . .... . .(2.31)
F-test 1.11. . .. . ..... . .(9.013)
The values in parenthesis are the corresponding theoretical values of t and
the reported method.
* Average of three determinations.the volume of Tb3+ ion or Tris buffer by ±0.5 ml, the ﬂuores-
cence intensity was not greatly affected.
3.4. Application of the proposed method
The proposed method was successfully applied to the determi-
nation of diosmin and hesperidin in tablets of different brands.
The concentrations of the drugs were calculated referring tosed ﬂuorimetric method and the reported one3 for the analysis of
Daﬂon 500 mg tablets Dioven 500 tablets
ed3 Proposed Reported3 Proposed Reported3
98.57 97.91 98.29 97.21
0.85 0.77 0.97 0.60
0.86 0.78 0.99 0.62
0.35 0.39 0.40 0.31
0.72 0.59 0.95 0.36
1.24 . . .. . .... . .(2.31) 1.95. . .. . .... . .(2.31)
1.23. . .. . ..... . .(9.013) 2.62. . .. . ..... . .(9.013)
F at P= 0.05, where n= 6 for the proposed method and n= 4 for
sed ﬂuorimetric method and the reported one3 for the analysis of
Veinatonic tablets
d3 Proposed Reported3
98.90 98.56
0.69 0.56
0.69 0.57
0.28 0.28
0.47 0.32
0.83. . .. . .... . .(2.31)
1.49. . .. . ..... . .(9.013)
F at P= 0.05, where n= 6 for the proposed method and n= 4 for
Table 6 Determination of diosmin and hesperidin in their dosage forms by the proposed method with the application of the standard
addition technique.
Item Taken (mol) Added (mol) Diosmin recovery%*
Diosed C 500 mg tablets Veinatonic tablets Daﬂon 500 mg tablets Dioven 500 tablets
4.93 · 106 4.93 · 106 97.28 99.58 99.28 97.88
8.27 · 106 98.74 99.28 99.14 98.74
1.15 · 105 98.05 98.38 98.45 98.15
Mean 98.02 99.08 98.96 98.26
±SD 0.73 0.62 0.44 0.44
% RSD 0.75 0.63 0.45 0.45
% REr 0.43 0.36 0.26 0.26
Variance 0.53 0.39 0.20 0.19
Hesperidin recovery%*
4.91 · 106 3.28 · 106 98.05 98.59
4.91 · 106 97.04 99.69
9.83 · 106 98.34 98.72
Mean 97.81 99.00
±SD 0.68 0.60
% RSD 0.70 0.61
% REr 0.40 0.35
Variance 0.47 0.36
* Average of three determinations.
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excipients did not interfere in the analysis as indicated by the
percentages found. The results obtained are abridged in Tables
4 and 5 and were in accordance with those obtained from the
reported method.3 Statistical analysis37 obtained by the pro-
posed and reported methods using Student’s t-test and vari-
ance ratio F-test, revealed no signiﬁcant difference between
the performance of the two methods regarding the accuracy
and precision, respectively. The results of the standard addi-
tion technique are cited in Table 6.
The method was further applied for the assay of the two
drugs in spiked plasma samples. It has been reported that after
oral administration; diosmin5 and hesperidin39 are rapidly
hydrolyzed by enzymes of the intestinal microﬂora into their
ﬂavone aglycone, diosmetin and hesperitin, respectively, which
are subsequently absorbed into the systemic circulation. How-
ever, the metabolites still carry the target chemical groups that
undergo the ﬂuorigenic reaction of concern thus; analysis of
the cited drugs in plasma could be applied. The plasma sam-
ples were spiked with different concentrations of the standards
of both drugs and deproteinization was carried out by the
addition of acetonitrile which is the most effective solvent
for precipitation of proteins. However, the ﬂuorescence inten-
sity of the ﬁnal experimental solution was greatly decreased by
the presence of acetonitrile, hence, the acetonitrile layer was
evaporated to dryness and the residues containing the drugsTable 7 Statistical data of the proposed ﬂuorimetric method
for the analysis of diosmin and hesperidin in spiked plasma
samples.
Parameter Diosmin Hesperidin
X ± SD 95.74 ± 1.90 96.32 ± 1.52
% RSD 1.99 1.58
% REr 0.81 0.64
Variance 3.62 2.31were reconstituted in the corresponding dissolving solvents.
After optimizing the extraction procedure, the proposed meth-
od proved to be suitable for the determination of diosmin and
hesperidin in spiked plasma samples with mean recoveries
95.74% and 96.32% and percentage relative standard devia-
tions of 1.99 and 1.58, respectively, as shown in Table 7.4. Conclusion
In this study a ﬂuorimetric method was successfully developed
for the determination of diosmin and hesperidin. This method
is based on the quenching of ﬂuorescence produced by these
drugs on Tb3+––Tris system. The proposed method is charac-
terized by being simple, rapid, cheap and needs neither expen-
sive solvents nor sophisticated apparatus. The method has
proved to be successful for the determination of the studied
drugs in bulk powder, combined dosage forms and spiked plas-
ma samples. The simplicity and sensitivity of this method allow
its use in the quality control of the cited drugs and can be ex-
tended for routine analysis of the drugs in their dosage forms.
5. Conﬂict of interest
None.
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